Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

This study has been completed.
Information provided by Abbott

Please refer to this study by its ClinicalTrials.gov identifier: NCT00292396

Locations


United States, Illinois
	Global Medical Information - Abbott
	Abbott Park, Illinois, United States, 60064

Sponsors and Collaborators

Abbott

Investigators


Study Director:	Beverly Paperiello	Abbott